How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.

Om Podcasten

Explore how the latest technologies are shaping our world, from groundbreaking discoveries to transformative sustainability efforts. The NVIDIA AI Podcast shines a light on the stories and solutions behind the most innovative changes, helping to inspire and educate listeners. Every week, we’ll bring you another tale, another 30-minute interview, as we build a real-time oral history of AI that’s already garnered nearly 6.5 million listens and been acclaimed as one of the best AI and machine learning podcasts. Listen in and get inspired. More information: https://ai-podcast.nvidia.com/